{"transactions":[{"id":1619562,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-27T00:31:36.000Z","date":"2024-02-22","kind":"sale","planned":true,"acquired":false,"shares":14568,"price":10.0456,"value":146344.3008,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units."}],"balance_after":250111,"source":{"system":"sec-edgar","filing":"0001628280-24-006982","document":"wk-form4_1708993886.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828024006982/wk-form4_1708993886.xml","form_type":"4"}},{"id":1638314,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-16T23:56:49.000Z","date":"2024-02-16","kind":"sale","planned":true,"acquired":false,"shares":3321,"price":10.2396,"value":34005.7116,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units."}],"balance_after":264679,"source":{"system":"sec-edgar","filing":"0001628280-24-005418","document":"wk-form4_1708127793.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828024005418/wk-form4_1708127793.xml","form_type":"4"}},{"id":1692625,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-03T19:47:59.000Z","date":"2024-01-02","kind":"exercise","planned":false,"acquired":false,"shares":47591,"price":1.53,"value":72814.23,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the stock option vested and became exercisable on April 27, 2019, and the remaining shares vested in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":1.53,"expiration_date":"2028-04-27","underlying":"Common Stock","underlying_shares":47591},"source":{"system":"sec-edgar","filing":"0001628280-24-000169","document":"wk-form4_1704311270.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828024000169/wk-form4_1704311270.xml","form_type":"4"}},{"id":1692624,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-03T19:47:59.000Z","date":"2024-01-02","kind":"exercise","planned":false,"acquired":false,"shares":13576,"price":1.575,"value":21382.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vested in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":1.575,"expiration_date":"2028-07-19","underlying":"Common Stock","underlying_shares":13576},"source":{"system":"sec-edgar","filing":"0001628280-24-000169","document":"wk-form4_1704311270.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828024000169/wk-form4_1704311270.xml","form_type":"4"}},{"id":1692623,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-03T19:47:59.000Z","date":"2024-01-02","kind":"exercise","planned":false,"acquired":false,"shares":18833,"price":0.855,"value":16102.215,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4 of the  shares subject to the stock option vested and became exercisable on December 14, 2017, and the remaining shares vested in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":0.855,"expiration_date":"2027-03-09","underlying":"Common Stock","underlying_shares":18833},"source":{"system":"sec-edgar","filing":"0001628280-24-000169","document":"wk-form4_1704311270.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828024000169/wk-form4_1704311270.xml","form_type":"4"}},{"id":1692622,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-01-03T19:47:59.000Z","date":"2024-01-02","kind":"exercise","planned":false,"acquired":true,"shares":47591,"price":1.53,"value":72814.23,"ownership":{"direct":true},"balance_after":268000,"source":{"system":"sec-edgar","filing":"0001628280-24-000169","document":"wk-form4_1704311270.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828024000169/wk-form4_1704311270.xml","form_type":"4"}},{"id":1692621,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-01-03T19:47:59.000Z","date":"2024-01-02","kind":"exercise","planned":false,"acquired":true,"shares":13576,"price":1.575,"value":21382.2,"ownership":{"direct":true},"balance_after":220409,"source":{"system":"sec-edgar","filing":"0001628280-24-000169","document":"wk-form4_1704311270.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828024000169/wk-form4_1704311270.xml","form_type":"4"}},{"id":1692620,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-01-03T19:47:59.000Z","date":"2024-01-02","kind":"exercise","planned":false,"acquired":true,"shares":18833,"price":0.855,"value":16102.215,"ownership":{"direct":true},"balance_after":206833,"source":{"system":"sec-edgar","filing":"0001628280-24-000169","document":"wk-form4_1704311270.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828024000169/wk-form4_1704311270.xml","form_type":"4"}},{"id":1862415,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-08T20:30:34.000Z","date":"2023-06-07","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the stock option vested and became exercisable on April 27, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":47591,"derivative":{"exercise_price":1.53,"expiration_date":"2028-04-27","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-23-035409","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123035409/doc4.xml","form_type":"4"}},{"id":1862414,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-06-08T20:30:34.000Z","date":"2023-06-07","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":25.9454,"value":129727.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.63 to $26.31 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":188000,"source":{"system":"sec-edgar","filing":"0001209191-23-035409","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123035409/doc4.xml","form_type":"4"}},{"id":1862413,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-06-08T20:30:34.000Z","date":"2023-06-07","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":1.53,"value":7650.0,"ownership":{"direct":true},"balance_after":193000,"source":{"system":"sec-edgar","filing":"0001209191-23-035409","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123035409/doc4.xml","form_type":"4"}},{"id":1987135,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-02-28T21:39:12.000Z","date":"2023-02-27","kind":"sale","acquired":false,"shares":1400,"price":23.5601,"value":32984.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 28, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.47 to $23.68 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":188000,"source":{"system":"sec-edgar","filing":"0001209191-23-013683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123013683/doc4.xml","form_type":"4"}},{"id":1987134,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-02-28T21:39:12.000Z","date":"2023-02-27","kind":"sale","acquired":false,"shares":8920,"price":23.0029,"value":205185.868,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 28, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.47 to $23.46 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":189400,"source":{"system":"sec-edgar","filing":"0001209191-23-013683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123013683/doc4.xml","form_type":"4"}},{"id":1993354,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-25T01:29:47.000Z","date":"2023-02-22","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the stock option vest and become exercisable on February 22, 2024, and the remainder vest in 36 equal monthly installments thereafter."}],"balance_after":70000,"derivative":{"exercise_price":27.01,"expiration_date":"2033-02-21","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001209191-23-012996","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123012996/doc4.xml","form_type":"4"}},{"id":1993353,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-02-25T01:29:47.000Z","date":"2023-02-23","kind":"sale","acquired":false,"shares":2878,"price":25.973,"value":74750.294,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units."}],"balance_after":198320,"source":{"system":"sec-edgar","filing":"0001209191-23-012996","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123012996/doc4.xml","form_type":"4"}},{"id":1993352,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-02-25T01:29:47.000Z","date":"2023-02-22","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan."}],"balance_after":201198,"source":{"system":"sec-edgar","filing":"0001209191-23-012996","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123012996/doc4.xml","form_type":"4"}},{"id":2003608,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-02-22T00:24:15.000Z","date":"2023-02-17","kind":"sale","acquired":false,"shares":2802,"price":25.288,"value":70856.976,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units."}],"balance_after":141198,"source":{"system":"sec-edgar","filing":"0001209191-23-011384","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123011384/doc4.xml","form_type":"4"}},{"id":2046415,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-26T01:01:49.000Z","date":"2023-01-24","kind":"exercise","acquired":false,"shares":4594,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the shares subject to the stock option vested and became exercisable on March 11, 2020, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":37535,"derivative":{"exercise_price":5.175,"expiration_date":"2029-03-11","underlying":"Common Stock","underlying_shares":4594},"source":{"system":"sec-edgar","filing":"0001209191-23-004945","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123004945/doc4.xml","form_type":"4"}},{"id":2046414,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-26T01:01:49.000Z","date":"2023-01-24","kind":"exercise","acquired":false,"shares":25406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":13576,"derivative":{"exercise_price":1.575,"expiration_date":"2028-07-19","underlying":"Common Stock","underlying_shares":25406},"source":{"system":"sec-edgar","filing":"0001209191-23-004945","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123004945/doc4.xml","form_type":"4"}},{"id":2046413,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-26T01:01:49.000Z","date":"2023-01-24","kind":"sale","acquired":false,"shares":30000,"price":30.0019,"value":900057.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 28, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":144000,"source":{"system":"sec-edgar","filing":"0001209191-23-004945","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123004945/doc4.xml","form_type":"4"}},{"id":2046412,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-26T01:01:49.000Z","date":"2023-01-24","kind":"grant","acquired":true,"shares":4594,"price":5.175,"value":23773.95,"ownership":{"direct":true},"balance_after":174000,"source":{"system":"sec-edgar","filing":"0001209191-23-004945","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123004945/doc4.xml","form_type":"4"}},{"id":2046411,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-26T01:01:49.000Z","date":"2023-01-24","kind":"grant","acquired":true,"shares":25406,"price":1.575,"value":40014.45,"ownership":{"direct":true},"balance_after":169406,"source":{"system":"sec-edgar","filing":"0001209191-23-004945","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123004945/doc4.xml","form_type":"4"}},{"id":2203966,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-21T20:10:59.000Z","date":"2022-07-20","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":38982,"derivative":{"exercise_price":1.575,"expiration_date":"2028-07-19","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-22-042844","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122042844/doc4.xml","form_type":"4"}},{"id":2203965,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-07-21T20:10:59.000Z","date":"2022-07-20","kind":"sale","acquired":false,"shares":5000,"price":30,"value":150000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 28, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":144000,"source":{"system":"sec-edgar","filing":"0001209191-22-042844","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122042844/doc4.xml","form_type":"4"}},{"id":2203964,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-07-21T20:10:59.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":5000,"price":1.575,"value":7875.0,"ownership":{"direct":true},"balance_after":149000,"source":{"system":"sec-edgar","filing":"0001209191-22-042844","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122042844/doc4.xml","form_type":"4"}},{"id":2224196,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-06-22T21:40:30.000Z","date":"2022-06-21","kind":"sale","acquired":false,"shares":4991,"price":24.8866,"value":124209.0206,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 28, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.55 to $25.22 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":144000,"source":{"system":"sec-edgar","filing":"0001209191-22-038737","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122038737/doc4.xml","form_type":"4"}},{"id":2224195,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-06-22T21:40:30.000Z","date":"2022-04-15","kind":"gift","acquired":false,"shares":7777,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":148991,"source":{"system":"sec-edgar","filing":"0001209191-22-038737","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122038737/doc4.xml","form_type":"4"}},{"id":2374906,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-25T02:33:10.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":64000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the stock option vest and become exercisable on February 22, 2023, and the remainder vest in 36 equal monthly installments thereafter."}],"balance_after":64000,"derivative":{"exercise_price":29.48,"expiration_date":"2032-02-21","underlying":"Common Stock","underlying_shares":64000},"source":{"system":"sec-edgar","filing":"0001209191-22-012954","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122012954/doc4.xml","form_type":"4"}},{"id":2374905,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-02-25T02:33:10.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":67000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan."}],"balance_after":156768,"source":{"system":"sec-edgar","filing":"0001209191-22-012954","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122012954/doc4.xml","form_type":"4"}},{"id":2385510,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-18T21:47:11.000Z","date":"2022-02-16","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the stock option vested and became exercisable on April 27, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":52591,"derivative":{"exercise_price":1.53,"expiration_date":"2028-04-27","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-22-011338","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122011338/doc4.xml","form_type":"4"}},{"id":2385509,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-02-18T21:47:11.000Z","date":"2022-02-17","kind":"sale","acquired":false,"shares":3009,"price":31.9308,"value":96079.7772,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units."}],"balance_after":89768,"source":{"system":"sec-edgar","filing":"0001209191-22-011338","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122011338/doc4.xml","form_type":"4"}},{"id":2385508,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-02-18T21:47:11.000Z","date":"2022-02-16","kind":"sale","acquired":false,"shares":5000,"price":31.54,"value":157700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021."}],"balance_after":92777,"source":{"system":"sec-edgar","filing":"0001209191-22-011338","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122011338/doc4.xml","form_type":"4"}},{"id":2385507,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-02-18T21:47:11.000Z","date":"2022-02-16","kind":"exercise","acquired":true,"shares":5000,"price":1.53,"value":7650.0,"ownership":{"direct":true},"balance_after":97777,"source":{"system":"sec-edgar","filing":"0001209191-22-011338","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122011338/doc4.xml","form_type":"4"}},{"id":2411725,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-04T22:03:45.000Z","date":"2022-02-02","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the stock option vested and became exercisable on April 27, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":57591,"derivative":{"exercise_price":1.53,"expiration_date":"2028-04-27","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-22-007235","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122007235/doc4.xml","form_type":"4"}},{"id":2411724,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-02-04T22:03:45.000Z","date":"2022-02-02","kind":"sale","acquired":false,"shares":5000,"price":34.5239,"value":172619.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.13 to $35.04 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":92777,"source":{"system":"sec-edgar","filing":"0001209191-22-007235","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122007235/doc4.xml","form_type":"4"}},{"id":2411723,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-02-04T22:03:45.000Z","date":"2022-02-02","kind":"exercise","acquired":true,"shares":5000,"price":1.53,"value":7650.0,"ownership":{"direct":true},"balance_after":97777,"source":{"system":"sec-edgar","filing":"0001209191-22-007235","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122007235/doc4.xml","form_type":"4"}},{"id":2430641,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-20T22:55:40.000Z","date":"2022-01-19","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the shares subject to the stock option vested and became exercisable on April 27, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":62591,"derivative":{"exercise_price":1.53,"expiration_date":"2028-04-27","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-22-004143","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122004143/doc4.xml","form_type":"4"}},{"id":2430640,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-01-20T22:55:40.000Z","date":"2022-01-19","kind":"sale","acquired":false,"shares":2542,"price":35.5193,"value":90290.0606,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.13 to $35.865 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":92777,"source":{"system":"sec-edgar","filing":"0001209191-22-004143","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122004143/doc4.xml","form_type":"4"}},{"id":2430639,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-01-20T22:55:40.000Z","date":"2022-01-19","kind":"sale","acquired":false,"shares":2458,"price":34.5867,"value":85014.1086,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.12 to $35.06 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":95319,"source":{"system":"sec-edgar","filing":"0001209191-22-004143","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122004143/doc4.xml","form_type":"4"}},{"id":2430638,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-01-20T22:55:40.000Z","date":"2022-01-19","kind":"exercise","acquired":true,"shares":5000,"price":1.53,"value":7650.0,"ownership":{"direct":true},"balance_after":97777,"source":{"system":"sec-edgar","filing":"0001209191-22-004143","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122004143/doc4.xml","form_type":"4"}},{"id":2441672,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-07T00:48:31.000Z","date":"2022-01-05","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the stock option vested and became exercisable on April 27, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":67591,"derivative":{"exercise_price":1.53,"expiration_date":"2018-04-27","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-22-002257","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122002257/doc4.xml","form_type":"4"}},{"id":2441671,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-01-07T00:48:31.000Z","date":"2022-01-05","kind":"sale","acquired":false,"shares":400,"price":37.78,"value":15112.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021."}],"balance_after":92777,"source":{"system":"sec-edgar","filing":"0001209191-22-002257","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122002257/doc4.xml","form_type":"4"}},{"id":2441670,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-01-07T00:48:31.000Z","date":"2022-01-05","kind":"sale","acquired":false,"shares":4600,"price":37.14,"value":170844.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.76 to $37.49 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":93177,"source":{"system":"sec-edgar","filing":"0001209191-22-002257","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122002257/doc4.xml","form_type":"4"}},{"id":2441669,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-01-07T00:48:31.000Z","date":"2022-01-05","kind":"exercise","acquired":true,"shares":5000,"price":1.53,"value":7650.0,"ownership":{"direct":true},"balance_after":97777,"source":{"system":"sec-edgar","filing":"0001209191-22-002257","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122002257/doc4.xml","form_type":"4"}},{"id":2466334,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-17T22:01:18.000Z","date":"2021-12-15","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/4 of the shares subject to the stock option vested and became exercisable on April 27, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":72591,"derivative":{"exercise_price":1.53,"expiration_date":"2018-04-27","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-21-070325","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121070325/doc4.xml","form_type":"4"}},{"id":2466333,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-12-17T22:01:18.000Z","date":"2021-12-15","kind":"sale","acquired":false,"shares":1200,"price":52.2004,"value":62640.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.01 to $52.59 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":92777,"source":{"system":"sec-edgar","filing":"0001209191-21-070325","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121070325/doc4.xml","form_type":"4"}},{"id":2466332,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-12-17T22:01:18.000Z","date":"2021-12-15","kind":"sale","acquired":false,"shares":1034,"price":51.2957,"value":53039.7538,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.00 to $51.95 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":93977,"source":{"system":"sec-edgar","filing":"0001209191-21-070325","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121070325/doc4.xml","form_type":"4"}},{"id":2466331,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-12-17T22:01:18.000Z","date":"2021-12-15","kind":"sale","acquired":false,"shares":1050,"price":50.603,"value":53133.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.9825 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":95011,"source":{"system":"sec-edgar","filing":"0001209191-21-070325","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121070325/doc4.xml","form_type":"4"}},{"id":2466330,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-12-17T22:01:18.000Z","date":"2021-12-15","kind":"sale","acquired":false,"shares":1716,"price":49.4142,"value":84794.7672,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.91 to $49.83 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":96061,"source":{"system":"sec-edgar","filing":"0001209191-21-070325","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121070325/doc4.xml","form_type":"4"}},{"id":2466329,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-12-17T22:01:18.000Z","date":"2021-12-15","kind":"exercise","acquired":true,"shares":5000,"price":1.53,"value":7650.0,"ownership":{"direct":true},"balance_after":97777,"source":{"system":"sec-edgar","filing":"0001209191-21-070325","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121070325/doc4.xml","form_type":"4"}},{"id":2486003,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-12-03T22:22:20.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":91,"price":44.97,"value":4092.27,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021."}],"balance_after":92777,"source":{"system":"sec-edgar","filing":"0001209191-21-067918","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121067918/doc4.xml","form_type":"4"}},{"id":2486002,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-12-03T22:22:20.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":2050,"price":44.1,"value":90405.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.84 to $44.49 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":92868,"source":{"system":"sec-edgar","filing":"0001209191-21-067918","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121067918/doc4.xml","form_type":"4"}},{"id":2486001,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-12-03T22:22:20.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":4409,"price":43.46,"value":191615.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.83 to $43.81 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":94918,"source":{"system":"sec-edgar","filing":"0001209191-21-067918","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121067918/doc4.xml","form_type":"4"}},{"id":2486000,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-12-03T22:22:20.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":950,"price":41.82,"value":39729.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.41 to $42.31 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":99327,"source":{"system":"sec-edgar","filing":"0001209191-21-067918","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121067918/doc4.xml","form_type":"4"}},{"id":2502968,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-19T21:51:21.000Z","date":"2021-11-17","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the shares subject to the stock option vested and became exercisable on March 11, 2020, and the remaining shares will vest in 36 equal monthly installments thereafter."}],"balance_after":42129,"derivative":{"exercise_price":5.175,"expiration_date":"2029-03-10","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-21-065833","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121065833/doc4.xml","form_type":"4"}},{"id":2502967,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-11-19T21:51:21.000Z","date":"2021-11-17","kind":"sale","acquired":false,"shares":465,"price":36.8003,"value":17112.1395,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.25 to $37.09 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":100277,"source":{"system":"sec-edgar","filing":"0001209191-21-065833","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121065833/doc4.xml","form_type":"4"}},{"id":2502966,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-11-19T21:51:21.000Z","date":"2021-11-17","kind":"sale","acquired":false,"shares":4535,"price":35.7536,"value":162142.576,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.21 to $35.99 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":100742,"source":{"system":"sec-edgar","filing":"0001209191-21-065833","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121065833/doc4.xml","form_type":"4"}},{"id":2502965,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-11-19T21:51:21.000Z","date":"2021-11-17","kind":"exercise","acquired":true,"shares":5000,"price":5.175,"value":25875.0,"ownership":{"direct":true},"balance_after":105277,"source":{"system":"sec-edgar","filing":"0001209191-21-065833","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121065833/doc4.xml","form_type":"4"}},{"id":2524581,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-04T23:14:23.000Z","date":"2021-11-03","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the stock option vested and became exercisable on March 11, 2020, and the remaining shares will vest in 36 equal monthly installments thereafter."}],"balance_after":47129,"derivative":{"exercise_price":5.175,"expiration_date":"2029-03-10","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-21-063007","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121063007/doc4.xml","form_type":"4"}},{"id":2524580,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-11-04T23:14:23.000Z","date":"2021-11-03","kind":"sale","acquired":false,"shares":5000,"price":36.4661,"value":182330.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.22 to $36.76 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":100277,"source":{"system":"sec-edgar","filing":"0001209191-21-063007","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121063007/doc4.xml","form_type":"4"}},{"id":2524579,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-11-04T23:14:23.000Z","date":"2021-11-03","kind":"exercise","acquired":true,"shares":5000,"price":5.175,"value":25875.0,"ownership":{"direct":true},"balance_after":105277,"source":{"system":"sec-edgar","filing":"0001209191-21-063007","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121063007/doc4.xml","form_type":"4"}},{"id":2536400,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-10-22T21:00:35.000Z","date":"2021-10-20","kind":"sale","acquired":false,"shares":4000,"price":39.649,"value":158596.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.50 to $39.89 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":100277,"source":{"system":"sec-edgar","filing":"0001209191-21-061384","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121061384/doc4.xml","form_type":"4"}},{"id":2546460,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-10-07T22:14:09.000Z","date":"2021-10-06","kind":"sale","acquired":false,"shares":5000,"price":34.5561,"value":172780.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.00 to $34.80 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":104277,"source":{"system":"sec-edgar","filing":"0001209191-21-059979","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121059979/doc4.xml","form_type":"4"}},{"id":2556624,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-09-29T21:00:13.000Z","date":"2021-09-27","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4 of the 111,110 shares originally subject to the stock option vested and became exercisable on December 14, 2017, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":18833,"derivative":{"exercise_price":0.855,"expiration_date":"2027-03-09","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-21-058071","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121058071/doc4.xml","form_type":"4"}},{"id":2556623,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-09-29T21:00:13.000Z","date":"2021-09-27","kind":"exercise","acquired":true,"shares":5000,"price":0.855,"value":4275.0,"ownership":{"direct":true},"balance_after":109277,"source":{"system":"sec-edgar","filing":"0001209191-21-058071","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121058071/doc4.xml","form_type":"4"}},{"id":2565879,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-09-17T19:44:10.000Z","date":"2021-09-15","kind":"sale","acquired":false,"shares":720,"price":50.36,"value":36259.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.282 to $50.45 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":104277,"source":{"system":"sec-edgar","filing":"0001209191-21-056602","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121056602/doc4.xml","form_type":"4"}},{"id":2565878,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-09-17T19:44:10.000Z","date":"2021-09-15","kind":"sale","acquired":false,"shares":4280,"price":49.58,"value":212202.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.19 to $50.06 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":104997,"source":{"system":"sec-edgar","filing":"0001209191-21-056602","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121056602/doc4.xml","form_type":"4"}},{"id":2581728,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-09-02T23:24:37.000Z","date":"2021-09-01","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/4 of the shares subject to the stock option vested and became exercisable on April 27, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":77591,"derivative":{"exercise_price":1.53,"expiration_date":"2028-04-27","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-21-054577","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121054577/doc4.xml","form_type":"4"}},{"id":2581727,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-09-02T23:24:37.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":2107,"price":50.4273,"value":106250.3211,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.295 to $50.56 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":109277,"source":{"system":"sec-edgar","filing":"0001209191-21-054577","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121054577/doc4.xml","form_type":"4"}},{"id":2581726,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-09-02T23:24:37.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":1005,"price":49.3954,"value":49642.377,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.28 to $49.775 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":111384,"source":{"system":"sec-edgar","filing":"0001209191-21-054577","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121054577/doc4.xml","form_type":"4"}},{"id":2581725,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-09-02T23:24:37.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":1888,"price":48.7215,"value":91986.192,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.16 to $49.10 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":112389,"source":{"system":"sec-edgar","filing":"0001209191-21-054577","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121054577/doc4.xml","form_type":"4"}},{"id":2581724,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-09-02T23:24:37.000Z","date":"2021-09-01","kind":"exercise","acquired":true,"shares":5000,"price":1.53,"value":7650.0,"ownership":{"direct":true},"balance_after":114277,"source":{"system":"sec-edgar","filing":"0001209191-21-054577","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121054577/doc4.xml","form_type":"4"}},{"id":2594929,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-08-20T20:52:15.000Z","date":"2021-08-18","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the stock option vested and became exercisable on April 27, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":82591,"derivative":{"exercise_price":1.53,"expiration_date":"2028-04-27","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-21-052790","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121052790/doc4.xml","form_type":"4"}},{"id":2594928,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-08-20T20:52:15.000Z","date":"2021-08-18","kind":"sale","acquired":false,"shares":5000,"price":42.2321,"value":211160.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.87 to $42.72 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":109277,"source":{"system":"sec-edgar","filing":"0001209191-21-052790","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121052790/doc4.xml","form_type":"4"}},{"id":2594927,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-08-20T20:52:15.000Z","date":"2021-08-18","kind":"exercise","acquired":true,"shares":5000,"price":1.53,"value":7650.0,"ownership":{"direct":true},"balance_after":114277,"source":{"system":"sec-edgar","filing":"0001209191-21-052790","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121052790/doc4.xml","form_type":"4"}},{"id":2613056,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-06T00:03:11.000Z","date":"2021-08-04","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the stock option vested and became exercisable on March 11, 2020, and the remaining shares will vest in 36 equal monthly installments thereafter."}],"balance_after":52129,"derivative":{"exercise_price":5.175,"expiration_date":"2029-03-10","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-21-050065","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121050065/doc4.xml","form_type":"4"}},{"id":2613055,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-08-06T00:03:11.000Z","date":"2021-08-04","kind":"sale","acquired":false,"shares":5000,"price":34.9208,"value":174604.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.61 to $35.15 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":109277,"source":{"system":"sec-edgar","filing":"0001209191-21-050065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121050065/doc4.xml","form_type":"4"}},{"id":2613054,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-08-06T00:03:11.000Z","date":"2021-08-04","kind":"exercise","acquired":true,"shares":5000,"price":5.175,"value":25875.0,"ownership":{"direct":true},"balance_after":114277,"source":{"system":"sec-edgar","filing":"0001209191-21-050065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121050065/doc4.xml","form_type":"4"}},{"id":2625947,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-23T21:00:18.000Z","date":"2021-07-21","kind":"exercise","acquired":false,"shares":4630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":43982,"derivative":{"exercise_price":1.575,"expiration_date":"2028-07-19","underlying":"Common Stock","underlying_shares":4630},"source":{"system":"sec-edgar","filing":"0001209191-21-047978","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121047978/doc4.xml","form_type":"4"}},{"id":2625946,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-07-23T21:00:18.000Z","date":"2021-07-21","kind":"sale","acquired":false,"shares":4630,"price":37.44,"value":173347.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.12 to $37.92 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":109277,"source":{"system":"sec-edgar","filing":"0001209191-21-047978","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121047978/doc4.xml","form_type":"4"}},{"id":2625945,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-07-23T21:00:18.000Z","date":"2021-07-21","kind":"exercise","acquired":true,"shares":4630,"price":1.575,"value":7292.25,"ownership":{"direct":true},"balance_after":113907,"source":{"system":"sec-edgar","filing":"0001209191-21-047978","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121047978/doc4.xml","form_type":"4"}},{"id":2638116,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-08T21:32:13.000Z","date":"2021-07-07","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the shares subject to the stock option vested and became exercisable on March 11, 2020, and the remaining shares will vest in 36 equal monthly installments thereafter."}],"balance_after":57129,"derivative":{"exercise_price":5.175,"expiration_date":"2029-03-10","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-21-046012","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121046012/doc4.xml","form_type":"4"}},{"id":2638115,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-07-08T21:32:13.000Z","date":"2021-07-07","kind":"sale","acquired":false,"shares":1495,"price":40.9089,"value":61158.8055,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.60 to $41.11 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":109277,"source":{"system":"sec-edgar","filing":"0001209191-21-046012","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121046012/doc4.xml","form_type":"4"}},{"id":2638114,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-07-08T21:32:13.000Z","date":"2021-07-07","kind":"sale","acquired":false,"shares":3505,"price":40.1632,"value":140772.016,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.60 to $40.57 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":110772,"source":{"system":"sec-edgar","filing":"0001209191-21-046012","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121046012/doc4.xml","form_type":"4"}},{"id":2638113,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-07-08T21:32:13.000Z","date":"2021-07-07","kind":"exercise","acquired":true,"shares":5000,"price":5.175,"value":25875.0,"ownership":{"direct":true},"balance_after":114277,"source":{"system":"sec-edgar","filing":"0001209191-21-046012","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121046012/doc4.xml","form_type":"4"}},{"id":2663928,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T21:04:04.000Z","date":"2021-06-16","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the stock option vested and became exercisable on March 11, 2020, and the remaining shares will vest in 36 equal monthly installments thereafter."}],"balance_after":62129,"derivative":{"exercise_price":5.175,"expiration_date":"2029-03-10","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-21-041516","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121041516/doc4.xml","form_type":"4"}},{"id":2663927,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-06-17T21:04:04.000Z","date":"2021-06-16","kind":"sale","acquired":false,"shares":5000,"price":43.6692,"value":218346.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.19 to $43.95 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":109277,"source":{"system":"sec-edgar","filing":"0001209191-21-041516","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121041516/doc4.xml","form_type":"4"}},{"id":2663926,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-06-17T21:04:04.000Z","date":"2021-06-16","kind":"exercise","acquired":true,"shares":5000,"price":5.175,"value":25875.0,"ownership":{"direct":true},"balance_after":114277,"source":{"system":"sec-edgar","filing":"0001209191-21-041516","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121041516/doc4.xml","form_type":"4"}},{"id":2683419,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-03T23:30:02.000Z","date":"2021-06-02","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the 111,110 shares originally subject to the stock option vested and became exercisable on December 14, 2017, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":23833,"derivative":{"exercise_price":0.855,"expiration_date":"2027-03-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-037937","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121037937/doc4.xml","form_type":"4"}},{"id":2683418,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-06-03T23:30:02.000Z","date":"2021-06-02","kind":"sale","acquired":false,"shares":300,"price":42.1833,"value":12654.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.09 to $42.23 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":109277,"source":{"system":"sec-edgar","filing":"0001209191-21-037937","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121037937/doc4.xml","form_type":"4"}},{"id":2683417,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-06-03T23:30:02.000Z","date":"2021-06-02","kind":"sale","acquired":false,"shares":9700,"price":41.4659,"value":402219.23,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.08 to $42.06 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":109577,"source":{"system":"sec-edgar","filing":"0001209191-21-037937","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121037937/doc4.xml","form_type":"4"}},{"id":2683416,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-06-03T23:30:02.000Z","date":"2021-06-02","kind":"exercise","acquired":true,"shares":10000,"price":0.855,"value":8550.0,"ownership":{"direct":true},"balance_after":119277,"source":{"system":"sec-edgar","filing":"0001209191-21-037937","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121037937/doc4.xml","form_type":"4"}},{"id":2850440,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-18T22:01:16.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":64000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the stock option vest and become exercisable on February 16, 2022, and the remainder vest in 36 equal monthly installments thereafter."}],"balance_after":64000,"derivative":{"exercise_price":67.38,"expiration_date":"2031-02-15","underlying":"Common Stock","underlying_shares":64000},"source":{"system":"sec-edgar","filing":"0001209191-21-011921","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121011921/doc4.xml","form_type":"4"}},{"id":2850439,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-18T22:01:16.000Z","date":"2021-02-16","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the 111,110 shares originally subject to the stock option vested and became exercisable on December 14, 2017, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":33833,"derivative":{"exercise_price":0.855,"expiration_date":"2027-03-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-011921","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121011921/doc4.xml","form_type":"4"}},{"id":2850438,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-02-18T22:01:16.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan."}],"balance_after":109277,"source":{"system":"sec-edgar","filing":"0001209191-21-011921","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121011921/doc4.xml","form_type":"4"}},{"id":2850437,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-02-18T22:01:16.000Z","date":"2021-02-16","kind":"exercise","acquired":true,"shares":10000,"price":0.855,"value":8550.0,"ownership":{"direct":true},"balance_after":77277,"source":{"system":"sec-edgar","filing":"0001209191-21-011921","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121011921/doc4.xml","form_type":"4"}},{"id":2854990,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-17T22:25:27.000Z","date":"2021-02-12","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4 of the 111,110 shares originally subject to the stock option vested and became exercisable on December 14, 2017, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":43833,"derivative":{"exercise_price":0.855,"expiration_date":"2027-03-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-011384","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121011384/doc4.xml","form_type":"4"}},{"id":2854989,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-02-17T22:25:27.000Z","date":"2021-02-12","kind":"exercise","acquired":true,"shares":10000,"price":0.855,"value":8550.0,"ownership":{"direct":true},"balance_after":67277,"source":{"system":"sec-edgar","filing":"0001209191-21-011384","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121011384/doc4.xml","form_type":"4"}},{"id":2962955,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-12-02T00:03:07.000Z","date":"2020-11-27","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4 of the 111,110 shares originally subject to the stock option vested and became exercisable on December 14, 2017, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":53833,"derivative":{"exercise_price":0.855,"expiration_date":"2027-03-09","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-20-060970","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120060970/doc4.xml","form_type":"4"}},{"id":2962954,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":93896,"kind":"person","name":"Pang Phillip","position":1,"cik":"0001787370","reported_name":"Pang Phillip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-12-02T00:03:07.000Z","date":"2020-11-27","kind":"exercise","acquired":true,"shares":7500,"price":0.855,"value":6412.5,"ownership":{"direct":true},"balance_after":57277,"source":{"system":"sec-edgar","filing":"0001209191-20-060970","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120060970/doc4.xml","form_type":"4"}}],"next_cursor":"2020-12-02T00:03:07.000000Z,2962954"}